The ÉáÄ̤Ρ¿Ê¿¶Ñ¡Ê¤¹¤ë¡Ë FTSE boss is on ¡ò4.5M - but they say they need MORE money
The number of Footsie ²ñ¼Ò¡¿·ø¤¤s ²¡¤·¿Ê¤á¤ëing for »Ùʧ¤¦¡¿Ä¶â rises for their Ĺ¡¤»ØƳ¼Ô (n)Ìò°÷¡¿(a)¼¹¹ÔÎϤΤ¢¤ës has jumped even after the ÉáÄ̤Ρ¿Ê¿¶Ñ¡Ê¤¹¤ë¡Ë salary ¹¶·â¤¹¤ë¡¤¾×Æͤ¹¤ë ¡ò4.5million, a ½Ï¹Í¤¹¤ë¡¿¹Íθ¤¹¤ë has ÌÀ¤é¤«¤Ë¤¹¤ë¡¿Ï³¤é¤¹d.
As the ¿³µÄ about boardroom Ķ²á ¶¯¤á¤ës, the ʬÀÏ by Deloitte showed that 16 FTSE 100 companies are looking to ²þ¤¤¹¤ë »Ùʧ¤¦¡¿Ä¶â À¯ºös this year.
This ´Þ¤às nine that ·×²è¡Ê¤¹¤ë¡Ë to °ÕÌ£¤¢¤ê¤²¤Ë Áý²Ã¤¹¤ë the ºÇÂç¸Â on ¿½¤·¹þ¤à¡¿¿½¤·½Ð to their boss.
Fat cat »Ùʧ¤¦¡¿Ä¶â: As the ¿³µÄ about boardroom Ķ²á ¶¯¤á¤ës, ʬÀÏ by Deloitte showed that 16 FTSE 100 companies are looking to ²þ¤¤¹¤ë »Ùʧ¤¦¡¿Ä¶â À¯ºös this year
This time last year, just four blue-ȾƳÂÎÁÇ»Òs were angling for big »Ùʧ¤¦¡¿Ä¶â rises, ¤Ë¤è¤ì¤Ð the Êó¹ð¡Ê¤¹¤ë¡Ë¡¿²±Â¬ from the accounting and auditing µðÂç¡Ê¤Ê¡Ë.
The ¸¦µæ is based on the first 55 Footsie ²ñ¼Ò¡¿·ø¤¤s to publish their ǯ¼¡¤Î Êó¹ð¡Ê¤¹¤ë¡Ë¡¿²±Â¬s this year.
The ¼ûÍס¦Í׵᤹¤ës for more generous ²ÄǽÀ¤Î¤¢¤ë rewards come ¤Ë¤â¤«¤«¤ï¤é¤º ÉáÄ̤Ρ¿Ê¿¶Ñ¡Ê¤¹¤ë¡Ë »Ùʧ¤¦¡¿Ä¶â for a FTSE 100 boss jumping 4 per cent to ¡ò4.5million last year.
Boardroom »Ùʧ¤¦¡¿Ä¶â has once again become a major ÌäÂ꡿ȯ¹Ô¤¹¤ë in the City as companies Áܤ·½Ð¤¹ to compete with US ¶¥ÁèÁê¼ês where salaries and ÆÃÊ̼êÅös are typically higher.
AstraZeneca was last week ·ã¤·¤¯Íɤ¹¤ëd by an Åê»ñ²È È¿Íð as 35?per cent of ³ô¼çs Åêɼ¡Ê¤¹¤ë¡Ëd against a ¼è°ú¡¤¶¨Äê that could see Ĺ¡¤»ØƳ¼Ô (n)Ìò°÷¡¿(a)¼¹¹ÔÎϤΤ¢¤ë Pascal Soriot paid as much as ¡ò18.7million this year.
The ¡Ê·ã¤·¤¤¡Ëȿȯ ¡Êµ¡¤Î¡Ë¥«¥à after ±Æ¶ÁÎϤΤ¢¤ë ³ô¼ç ¡Êa¡ËÃé¹ð¤Î¡¿¡Ên¡Ë·ÙÊó groups Glass Äߤ꤯¤µ¤Ó and ISS told Åê»ñ²Ès to Åêɼ¡Ê¤¹¤ë¡Ë against the ¡Æ²áÅÙ¤Î¡Ç »Ùʧ¤¦¡¿Ä¶⠷ײè¡Ê¤¹¤ë¡Ë at the pharma µðÂç¡Ê¤Ê¡Ë¡ Çs ǯ¼¡¤Î ²ñ¹ç.
However, the °ì³ç was ºÇ½ªÅª¤Ë Ä´°õ¤¹¤ëd off by ³ô¼çs thanks to À¼¤Î »Ù»ý¼Ôs of Soriot, ´Þ¤àing ºÇ¹â¤Î¡¤¤ò±Û¤¹ ³ô¼ç GQG Partners which said he was ¡Æmassively underpaid¡Ç.
Over the ½µËö, AstraZeneca chairman Michel Demare ¹¶·â¤¹¤ë¡¤¾×Æͤ¹¤ë out against proxy ½õ¸À¼Ôs for ¡ÆÆóÎÝÂÇ ´ð½às¡Ç that ¡Ædo serious ³²¡Ê¤òÍ¿¤¨¤ë¡Ë¡Ç to the competitiveness of British companies,
But it is not just UK pharma that is feeling the °µÎÏ over »Ùʧ¤¦¡¿Ä¶â. Smith & ±ù is ľÌ̤¹¤ëing its own Âзè after ³ô¼çs were last week ´«¤á¤ëd to ̵»ë¤¹¤ë¡¤Î䤿¤¯ÃǤï¤ë a »Ùʧ¤¦¡¿Ä¶â rise for its US-based boss.?
Under Äó°Æs from the London-̾Êí¡Ê¤ËºÜ¤»¤ë¡Ë¡¿É½¡Ê¤Ë¤¢¤²¤ë¡Ëd °åÎŤΠ´ï¶ñ¡¿È÷ÉÊ group, Ĺ¡¤»ØƳ¼Ô (n)Ìò°÷¡¿(a)¼¹¹ÔÎϤΤ¢¤ë Deepak Nath could receive ¡ò9.4million next year if he ²ñ¹ç¡¤²ñ¤¦s Ūs.
¼õ±×¼Ôs: AstraZeneca boss Pascal Soriot, left, and London ºß¸Ë¡¿³ô ¸òή Ĺ¡¤»ØƳ¼Ô exec David Schwimmer, ¸¢Íø, are ¤ÎÃæ¤Ç those in line for big »Ùʧ¤¦¡¿Ä¶â rises
But ISS has slammed it as ¡Æ²áÅÙ¤Î¡Ç and recommended that Åê»ñ²Ès µñÀ䤹¤ë it at next month¡Çs ǯ¼¡¤Î ²ñ¹ç.
The London ºß¸Ë¡¿³ô ¸òή Group is also looking to ǼÆÀ¤µ¤»¤ë ³ô¼çs later this month over »Ùʧ¤¦¡¿Ä¶â for its Ĺ¡¤»ØƳ¼Ô (n)Ìò°÷¡¿(a)¼¹¹ÔÎϤΤ¢¤ë David Schwimmer.
Under its ·×²è¡Ê¤¹¤ë¡Ës, he will have the chance to earn twice his ¸½ºß¤Î ºÇÂç¸Â °ì³ç of ¡ò6.25million.?
Mitul Shah, a Deloitte partner, who advises companies on their »Ùʧ¤¦¡¿Ä¶â À¯ºös, said the ·¹¸þ of ¡Æmore ²á·ã¤Ê »Ùʧ¤¦¡¿Ä¶â Äó°Æs¡Ç was É餫¤¹¡¿·âÄƤ¹¤ë to ³«»Ï¤¹¤ëing ¶¥Áè for talent.
He said: ¡ÆMany of these companies have a ½ÅÍ×¤Ê US ÂÀ× and Æõ¤¹¤ë¡¿°úÍѤ¹¤ë the ÉÔÊ¿Åù in »Ùʧ¤¦¡¿Ä¶â levels between the UK and US as a challenge when competing for and ÊÝ»ý¤¹¤ëing ¾åµé¤Î talent in a Á´À¤³¦¤Î marketplace.¡Ç
¼¨¤¹ Austin, a lawyer at Á´À¤³¦¤Î ˡΧ ²ñ¼Ò¡¿·ø¤¤ Latham & Watkins, said: ¡ÆIf large international London-̾Êí¡Ê¤ËºÜ¤»¤ë¡Ë¡¿É½¡Ê¤Ë¤¢¤²¤ë¡Ëd companies want to compete for talent globally, they need to be able to ¿½¤·¹þ¤à¡¿¿½¤·½Ð ¶¥Áè¤Î·ã¤·¤¤ Êä½þ¡Ê¶â¡Ë.¡Ç
¼çÍ×¤Ê ¾¦Çä¡¿»Å»ö ¿Íʪ¡¿»Ñ¡¿¿ô»ús in the City, ´Þ¤àing Julia Hoggett, who is Ĺ¡¤»ØƳ¼Ô e xecutive of the LSE Group¡Çs ³ô¼°»Ô¾ì ¾¦Çä¡¿»Å»ö, are ²¡¤·¿Ê¤á¤ëing for (n)Ìò°÷¡¿(a)¼¹¹ÔÎϤΤ¢¤ës to receive higher salaries. But some have flagged ´Ø¿´s about the growing ²¡¤·¿Ê¤á¤ë for (n)Ìò°÷¡¿(a)¼¹¹ÔÎϤΤ¢¤ë »Ùʧ¤¦¡¿Ä¶â.
Luke Hildyard, from the High »Ùʧ¤¦¡¿Ä¶â Centre, said: ¡ÆThis is ÌÀÇò¤Ë good news for Ĺ¡¤»ØƳ¼Ô (n)Ìò°÷¡¿(a)¼¹¹ÔÎϤΤ¢¤ës and other high ¼ýÆþ professionals. It remains to be seen what Íø±×s it will bring to the »Ä¤ê¡¿µÙ·Æ¡Ê¤¹¤ë¡Ë of the country.¡Ç